ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 137 filers reported holding ENANTA PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 8.04 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $720,000 | -60.5% | 13,990 | -52.5% | 0.02% | -39.4% |
| Q4 2019 | $1,821,000 | -25.3% | 29,479 | -27.3% | 0.03% | -23.3% |
| Q3 2019 | $2,437,000 | -10.7% | 40,570 | +25.4% | 0.04% | -2.3% |
| Q2 2019 | $2,729,000 | +53.1% | 32,345 | +73.4% | 0.04% | +69.2% |
| Q1 2019 | $1,782,000 | +11.9% | 18,652 | -17.0% | 0.03% | +4.0% |
| Q4 2018 | $1,592,000 | -38.4% | 22,482 | -25.6% | 0.02% | -30.6% |
| Q3 2018 | $2,584,000 | +47.0% | 30,234 | +99.3% | 0.04% | +44.0% |
| Q2 2018 | $1,758,000 | +42.5% | 15,172 | -0.5% | 0.02% | +47.1% |
| Q1 2018 | $1,234,000 | +86.4% | 15,249 | +35.2% | 0.02% | +70.0% |
| Q4 2017 | $662,000 | +16.8% | 11,276 | -6.9% | 0.01% | +25.0% |
| Q3 2017 | $567,000 | -18.2% | 12,112 | -37.1% | 0.01% | -20.0% |
| Q2 2017 | $693,000 | -41.7% | 19,268 | -50.1% | 0.01% | -33.3% |
| Q1 2017 | $1,188,000 | -30.0% | 38,581 | -23.8% | 0.02% | -31.8% |
| Q4 2016 | $1,696,000 | -7.0% | 50,629 | -26.1% | 0.02% | -8.3% |
| Q3 2016 | $1,823,000 | -25.7% | 68,514 | -38.4% | 0.02% | -17.2% |
| Q2 2016 | $2,453,000 | -5.8% | 111,236 | +25.5% | 0.03% | 0.0% |
| Q1 2016 | $2,603,000 | -76.9% | 88,631 | -71.6% | 0.03% | -73.6% |
| Q3 2015 | $11,270,000 | +118.7% | 311,850 | +172.3% | 0.11% | +155.8% |
| Q2 2015 | $5,153,000 | +251.5% | 114,532 | +139.3% | 0.04% | +290.9% |
| Q1 2015 | $1,466,000 | +153.6% | 47,871 | +321.1% | 0.01% | +120.0% |
| Q4 2014 | $578,000 | -72.0% | 11,367 | -78.2% | 0.01% | -76.2% |
| Q3 2014 | $2,067,000 | – | 52,230 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 936,777 | $53,218,000 | 16.69% |
| Fairmount Funds Management LLC | 316,952 | $18,006,000 | 6.55% |
| ARMISTICE CAPITAL, LLC | 1,836,000 | $104,303,000 | 1.77% |
| Soleus Capital Management, L.P. | 182,400 | $10,362,000 | 1.62% |
| Portland Global Advisors LLC | 62,635 | $3,558,000 | 0.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 40,000 | $2,263,000 | 0.55% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,995,000 | $113,336,000 | 0.53% |
| Yorktown Management & Research Co Inc | 10,400 | $591,000 | 0.44% |
| Hennion & Walsh Asset Management, Inc. | 120,240 | $6,831,000 | 0.36% |
| Virtus ETF Advisers LLC | 9,599 | $545,000 | 0.24% |